SCHEMBL4432399

SCHEMBL4432399

Cc1ccc(-c2ccc(C(F)(F)Oc3cc(F)c(F)c(F)c3)cc2)cc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN5 P54829 1/20 0.34
CYP1A2 P05177 1/20 0.33
MAPT P10636 1/20 0.33
CYP2C19 P33261 1/20 0.33
AR P10275 1/20 0.33
CYP11B1 P15538 1/20 0.33
CYP11B2 P19099 1/20 0.33
NPBWR1 P48145 1/20 0.33
CA1 P00915 1/20 0.32
CA2 P00918 1/20 0.32
CA5A P35218 1/20 0.32
CA9 Q16790 1/20 0.32
TSHR P16473 1/20 0.31
HTR2A P28223 1/20 0.31
SLC6A4 P31645 1/20 0.31
KCNH2 Q12809 1/20 0.31
PTGS2 P35354 2/20 0.31
PPARD Q03181 1/20 0.31
PDK2 Q15119 1/20 0.31
PTGS1 P23219 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2741545 0.95 TSHR (0.34) ARCA1CA2CA5ACA9
SCHEMBL18735552 0.92 CYP11B1 (0.32) PTPN5CYP11B1CYP11B2NPBWR1PPARD
SCHEMBL20380670 0.91 PTGS2 (0.34) CYP11B1CYP11B2NPBWR1PTGS2PDK2
SCHEMBL17548018 0.90 PTPN5 (0.34) PTPN5CYP1A2MAPTCYP2C19AR
SCHEMBL16866174 0.90 AKR1C3 (0.37) PTPN5MAPTCYP2C19PTGS2PDK2
SCHEMBL20003578 0.90 PTPN5 (0.31) PTPN5CYP1A2MAPTCYP2C19AR
SCHEMBL17548015 0.88 PPARD (0.34) PTPN5CYP1A2MAPTCYP2C19AR
SCHEMBL2741564 0.87 AKR1C3 (0.39) CYP2C19
SCHEMBL20380602 0.86 AKR1C3 (0.32) HTR2ASLC6A4KCNH2PTGS2PTGS1
SCHEMBL4431222 0.86 NFE2L2 (0.38) PTPN5CYP1A2MAPTCYP2C19AR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 89 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12043782-B2 Liquid crystalline medium MERCK PATENT GMBH (DE) 2024-07-23 US disclosed
US-11788009-B2 Liquid-crystalline medium for use in a switching element MERCK PATENT GMBH (DE) 2023-10-17 US disclosed
US-11760931-B2 Liquid-crystalline medium for use in a switching element MERCK PATENT GMBH (DE) 2023-09-19 US disclosed
US-11702597-B2 Azo dye MERCK PATENT GMBH (DE) 2023-07-18 US disclosed
US-11667845-B2 Liquid crystalline medium MERCK PATENT GMBH (DE) 2023-06-06 US disclosed
US-20230068853-A1 LIQUID CRYSTAL MIXTURE AND LIQUID CRYSTAL DISPLAY MERCK PATENT GMBH (DE) 2023-03-02 US disclosed
US-20230029961-A1 LIQUID CRYSTAL MEDIA COMPRISING POLYMERISABLE COMPOUNDS MERCK PATENT GMBH (DE) 2023-02-02 US disclosed
US-20220220383-A1 METHOD FOR PREPARING A LIQUID CRYSTAL-BASED SWITCHING ELEMENT MERCK PATENT GMBH (DE) 2022-07-14 US disclosed
US-11359141-B2 Additives for liquid crystal mixtures MERCK PATENT GMBH (DE) 2022-06-14 US disclosed
US-11353751-B2 Double layer liquid crystal device and process of manufacture MERCK PATENT GMBH (DE) 2022-06-07 US disclosed
US-20150048276-A1 LIQUID-CRYSTALLINE MEDIUM MERCK PATENT GMBH (DE) 2015-02-19 US disclosed
US-20150048276-A1 LIQUID-CRYSTALLINE MEDIUM MERCK PATENT GMBH (DE) 2015-02-19 US disclosed
EP-2806011-A1 LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY ELEMENT USING SAME DIC Corporation (JP) 2014-11-26 EP disclosed
US-20140061534-A1 LIQUID-CRYSTALLINE MEDIUM MERCK PATENT GMBH (DE) 2014-03-06 US disclosed
US-20140061534-A1 LIQUID-CRYSTALLINE MEDIUM MERCK PATENT GMBH (DE) 2014-03-06 US disclosed
WO-2012052104-A1 LIQUID-CRYSTALLINE MEDIUM AND LIQUID-CRYSTAL DISPLAY MERCK PATENT GMBH (DE) 2012-04-26 WO disclosed
US-7972664-B2 Liquid-crystalline medium MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2011-07-05 US disclosed
US-20100219375-A1 LIQUID-CRYSTALLINE MEDIUM WITTEK MICHAEL 2010-09-02 US disclosed
US-7678431-B2 Photostable liquid-crystalline medium MERCK PATENT GMBH (DE) 2010-03-16 US disclosed
US-20070237907-A1 PHOTOSTABLE LIQUID-CRYSTALLINE MEDIUM MANABE ATSUTAKA 2007-10-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11667845-B2 Liquid crystalline medium NEFM, CCNI, MYT1 PTPN5 3166/4885CYP1A2 295/4885MAPT 214/4885
US-20230068853-A1 LIQUID CRYSTAL MIXTURE AND LIQUID CRYSTAL DISPLAY CXCR1, PYM1, F11 PTPN5 461/4885CYP1A2 541/4885MAPT 533/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.